Notifications
Back

Our perspective on new drug development

In order to overcome the low success rate of developing new medicine, we employ biomarker-based approaches to develop novel therapeutics that have optimized drug effect and delivery to the target tissue.

Animals are just as important to us

We strive to bring new medicine that can improve the lives of our animal companions.

R&D and Continuous Growth

We aim to thrive in the R&D ecosystem that requires long term survival by generating a stable cash flow.

Our Areas of Expertise.

Where we can make the biggest change in the future of medicine.

  • 01

    Small Molecule Drugs

  • 02

    Proteolysis Targeting Chimera (PROTAC)

  • 03

    Microneedle Platform Technology

  • 04

    CDO Services for Supergenerics and 505(b)(2) Products

  • 05

    Drug Repurposing and Repositioning

  • 06

    Veterinary Health Care

Our Business Model

New Drug
development

Personalized medicine in clinical areas of interest

Platform
Technology

Application of proprietary drug delivery technology to pipeline products and repurposing candidates

Supergenerics/505(b)(2) & Dosage Form Development 

Contracted cash cow service

Veterinary Drug Development

Open collaboration

Our Pipeline

Contact Us .

Address

27 Dongtahcheomdansaneop 1-ro, Geumgand Penterium IX Tower #A-401, Hwaseong-si, Gyeonggi-do, South Korea

E-mail

Microneedle system
donghwan_kim@daewoongrx.co.kr

Global Business Development
jangalsrnl@daewoongrx.co.kr

Domestic Business Development
sanghan_park@daewoongrx.co.kr

Directions

27 Dongtahcheomdansaneop 1-ro, Geumgand Penterium IX Tower #A-401, Hwaseong-si, Gyeonggi-do, South Korea